Overview

The Clinical Trial of the Anti Hepatitis B Placenta Transfer Factor Injection

Status:
Unknown status
Trial end date:
2017-12-01
Target enrollment:
Participant gender:
Summary
Asses the efficacy and safety of the Anti hepatitis B placenta transfer factor injection in the treatment of HBeAg positive chronic hepatitis B.
Phase:
Phase 4
Details
Lead Sponsor:
Shineway Pharmaceutical Co.,Ltd
Treatments:
Entecavir